Investorideas.com


Be a guest or sponsor our podcasts - learn more about us : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; (NASDAQ: HUGE) (CSE: HUGE), (NASDAQ: SNDL), (CSE: TGIF)

Delta, Kelowna, BC - January 10, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/011020-StocksToWatch.mp3

Investor Ideas Potcasts, #Cannabis News and #Stocks on the Move; (NASDAQ: HUGE) (CSE: HUGE), (NASDAQ: SNDL), (CSE: TGIF)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few early announcements.

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) announced that its Class B Subordinate Voting Shares will commence trading on the Nasdaq Capital Market under the symbol 'HUGE' today, January 9, 2020. The Company's Class B Subordinate Voting Shares will continue to trade on the Canadian Securities Exchange under the symbol 'HUGE'.

"The listing of our shares on the Nasdaq Capital Market is a momentous moment and represents a paradigm shift in the outlook of FSD Pharma," said Dr. Raza Bokhari, Executive Co-Chairman and CEO. "Doing so offers us an opportunity to expand awareness of the company's specialty pharmaceutical lead asset, a micronized formulation of palmitolylethonalamide (micro-PEA), which by targeting the CB2 receptor of the endocannabinoid system of the human body, may help address the opioid crisis by developing opioid-sparing, FDA-approved prescription drugs. A NASDAQ listing also elevates our corporate profile to institutional investors."

Dr. Bokhari will present at Biotech Showcase 2020 in San Francisco on Monday, January 13, 2020 at 3:30 pm PT where he will provide an overview of the Company, as well as recent strides made to transform FSD Pharma into a specialty pharmaceutical R&D company.

Sundial Growers Inc. (NASDAQ: SNDL), a Canadian licensed cannabis producer and Vir Pharma Holdings Pty Ltd. (NASDAQ: VIR), an Australian importer and manufacturer of medical cannabis, today announced a three-year agreement where Sundial will supply medical cannabis oil for Vir Pharma's unique oral formulation for chronic pain that will be used for sales and clinical studies in Australia.

Vir Pharma's clinical studies contribute to the development of a proprietary cannabis-based prescription drug for Therapeutic Goods Administration (TGA) approval called Virabis. The drug is intended to treat chronic pain, providing patients with an alternative to current opioid-based treatments.

"This is a significant announcement for Sundial and our Heal (medical) business as it will lead to our first global exports and entry into Australian markets," said Brian Harriman, Chief Operating Officer of Sundial. "We're excited to be working with a leading company such as Vir Pharma to provide Australian patients with high-quality, cannabis-based therapies."

Pursuant to the Agreement, Sundial will work with Vir Pharma to develop a cannabis oil blend focused on chronic pain, which will be marketed under Vir Pharma's brand name, Virabis.

"At Vir Pharma, we believe that full spectrum cannabis medicines could be a useful second line therapy to reduce opiate consumption and enhance the lives of people living in chronic pain," said Joel Hardy, CEO. "This agreement provides us a high-quality and consistent supply of GMP cannabis oil that allows us to guarantee a quality supply chain of materials to create products for sale in Australia and to conduct a clinical development program."

The relationship between Sundial and Vir Pharma will enable shared learnings and capabilities, allowing both parties to leverage each other's expertise and opening the door to developing innovative medical cannabis therapies moving forward.

1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated and growth-orientated cannabis consumer packaged goods company, announced a licensing agreement between the Company's subsidiary, Alternative Medicine Association LLC and Capna Intellectual, Inc., developer of The Bloom Brand. The one-year agreement was executed in December and received state approval in January, and awards AMA the exclusive license to manufacture a wide range of Bloom™ products for the Nevada market.

Established in California in 2014, Bloom™ is now sold in over three hundred licensed retailers in California, Nevada, Washington and New Mexico, with further expansion planned for new markets in Oklahoma, Massachusetts and Canada.

In 2015, AMA was the first licensed cultivator in Southern Nevada. Today, AMA continues its tradition of cultivating craft cannabis in a newly-constructed, state-of-the-art, purpose-built facility in Las Vegas, offering consistency and scalability. Well-known for its premium quality cannabis products, AMA produces a variety of THC concentrates, as well as oils used in vape pen cartridges, with a variety of terpene profiles for flavours and aromas.

"Our companies focus on end-use cannabis products that provide the highest quality ingredients and that are safe for consumers", remarked Ms. Ester Vigil, President of 1933 Industries. "Our goal is to expand beyond our proprietary AMA products and represent the very best cannabis brands in Nevada, offering a full suite of differentiated product lines. Bloom™ is a brand we have been watching for some time, waiting for the opportune time to work together. We are impressed by the professionalism of the Bloom™ team and we are proud to represent such a highly rewarded brand in Nevada", Ms. Vigil continued.

Providing an experience that is as close to the cannabis plant as possible and delivered in a tasteful and convenient way, the Bloom™ licensed products include:

  • Bloom™ Vape - Original vapor method available in a 500mg cartridge
  • Bloom™ One - Disposable vapor method providing the same flavorful experience in a smaller, 350mg preloaded, disposable package
  • Bloom™ Dart - Pod vapor method includes CCELL's advanced ceramic heating elements for greater oil absorption
  • Bloom™> Drop - Oil infusion method comes with 800mg of oil with pre-activated THC. The oil can be added to flower, dabs or for infusing food for instant effects
  • Bloom™ Kit - Pocket-sized vape battery for Bloom cartridges, featuring a sleek buttonless design, which activates as one inhales

Bloom™ products do not contain any additives, PG, VG, or vitamin E Acetate.

"Consistency is at the core of everything we do, so it was integral for us to find the right partners to act as an extension of our vision," said CEO and co-founder of Bloom™, Mr. Vitaly Mekk, "We are thrilled to begin this partnership with 1933. Their extensive cannabis history and experience in Nevada give us confidence that we will be able to achieve our goals together."

Lastly Lift and Co 2020 in Vancouver kicked off to an optimistic start yesterday as speakers and panelists discussed the future of Cannabis 2.0 products, the Future of Psychedelics, Rebuilding Trust and Confidence and ended with a panel discussion on international markets over the next 12 months. Investorideas was live at the event and we have included a brief excerpt of the final panel which features Deepak Anand, Founder and CEO of Materia Venture and Zamina Walgi, VP of Retail and Consumer Markets Strategy of Aurora Cannabis, Andrew Miller, Head of Cannabis Business Development at Clever Leaves and Rosy Mondin, CEO of World Class Extractions.

Investorideas will also be conducting live interviews at Lift and Co Vancouver 2020 today.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories